Küçükyurt Kaya S, Koca O, Aydın Kaynar L, Savaş EM, Azaklı O, Akı ŞZ, Albayrak M, Afacan Öztürk HB, Erdem HB, Güneş AK. Comparative prognostic performance of ELN 2022 and ELN 2024 risk classifications in a Turkish cohort of acute myeloid leukemia patients receiving hypomethylating agents and BCL-2 inhibitors. Acta Medica [Internet]. 2026 Jun. 28 [cited 2026 Jun. 29];57(2):157-65. Available from: https://www.actamedica.org/index.php/actamedica/article/view/1271